“Introduction of new systems, rise in the aging population, rising incidence of chronic illness and numerous needle free drug delivery systems in the pipeline will help the global needle free drug delivery market thrive”, says RNCOS.
Noida, UP -- (SBWIRE) -- 06/03/2015 -- According to a new research report by RNCOS entitled, "Global Needle Free Drug Delivery Market Outlook 2020", the US market has been witnessing higher growth in global needle free drug delivery industry, in 2014, US needle free drug delivery market accounted for over 40% of the global needle free drug delivery market, generating approximately US$ 45 Billion revenue.
Introduction of innovative vaccine delivery systems produced through technologically advanced techniques is helping countries to increase their vaccine coverage ratio. More and more people are becoming aware of the technically advanced drug delivery systems and are using them to get rid of painful and risky injections. However, the industry faces some challenges such as low awareness, lengthy needle free drug delivery systems' development procedure and testing and regulatory issues. Companies such as GSK, Novartis, 3M, Endo International, Boehringer Ingelheim Group and AstraZeneca are some of the larger players, whereas smaller players in the market include Bioject, Antares Pharmaceuticals, Cipla, Skyepharma etc.
The report is spread in over 80 pages and provides an in-depth research and rational analysis of the current status and future prospect of the Global Needle Free Drug Delivery Industry. The study presents transparent picture major needle free drug delivery systems such as Jet Injector, Micro Needle, Transdermal, Oral and Inhaled systems including the factors affecting their growth. The research further covers global needle free drug delivery system industry, detailed analysis of geographical segments, applications of needle free drug delivery systems, pipeline analysis, as well as Mergers and Acquisitions.
The report also covers detailed information about active market players in the Global Needle Free Drug Delivery Industry, including small and large players to enable the clients understand the market structure and its growth during the forecasted period. In brief, the report covers all the necessary aspects of the global needle free drug delivery system industry, providing an in-depth research and prudent analysis of the key segments.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM751.htm
Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm
RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.